Sign in
Enrolling by invitationNo phase

Throat muscle pressure measured in adults with obstructive sleep apnea using myofunctional therapy

Tests myofunctional therapy devices in 30 adults with obstructive sleep apnea.

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
Myofunctional Therapy for Obstructive Sleep Apnea
Status
Enrolling by invitation
People taking part
30 people, planned
Started
27 Oct 2026
Expected to end
30 Sept 2027
Type of study
Interventional
Treatments tested
  • Myofunctional Therapy
Record updated
28 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for 30 adults with obstructive sleep apnea (OSA). Everyone uses myofunctional therapy devices, which train the throat muscles, for 3 months.

Age
18 to 65 years
Sex
All sexes
Disease stage
Newly diagnosed OSA (AHI ≥ 5), or OSA where first-line treatment did not work. AHI counts breathing pauses per hour of sleep.
Earlier treatment
People must be willing to skip first-line OSA treatment, or stop their current OSA treatment, for 3 months.

Main reasons for not taking part

  • Health problems that require limiting fluids, such as swallowing problems, kidney or liver disease, or low blood sodium
  • Body mass index (BMI) ≥30 kg/m2
  • Severe nose blockage (NOSE score >15), severe lung disease, or heart failure, recent stroke or heart attack
  • Pregnancy, history of traumatic brain injury, or allergy to numbing medicine applied to the skin or lining
  • Severe PTSD (PCL-5 >33), very severe insomnia (ISI >22), or severe daytime sleepiness

The registry criteria, word for word

Show all 24 criteriaShow less

Who can take part

  • Adults aged 18-65
  • New diagnosis of OSA (AHI ≥ 5) or failure of first-line OSA treatment
  • Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months

Who cannot take part

  • Recent nasal, pharyngeal, laryngeal, or esophageal surgery
  • Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia)
  • Severe pulmonary disease
  • Severe post-traumatic stress disorder (PCL-5 \> 33)
  • History of TBI
  • Allergy to topical anesthetic
  • Current upper respiratory infection
  • Heart failure, recent stroke, heart attack, etc
  • Severe nasal obstruction
  • Severe ankyloglossia
  • Craniofacial abnormality
  • Very severe insomnia (ISI \> 22)
  • Body mass index (BMI) ≥30 kg/m2
  • Known oropharyngeal or esophageal dysphagia
  • Pregnancy
  • Inability to fast for 6 hours
  • Recent facial trauma
  • Known nasal, pharyngeal or esophageal obstruction
  • Insufficient internet/computer access to participate in remote study visit
  • Severe excessive daytime sleepiness (risk of motor vehicle accidents)
  • Nasal Obstruction Symptom Evaluation (NOSE) Scale \>15

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of MinnesotaMinneapolis, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of this study is to explore a new way to examine the function of the muscles using a technique called high-resolution manometry. The study will enroll 30 adults with OSA, all of whom will use the myofunctional therapy (MFT) devices for 3 months. High-resolution manometry will be used to measure the amount of pressure generated by the muscles of the throat when drinking water or breathing air, both with and without the MFT devices, and before and after the MFT intervention. If successful, this method can help us understand why sleep improves after MFT.

The group in the trial

  • Myofunctional TherapyTreatment being tested

    The intervention consists of 90 days of MFT (5-6 days/week) along with completing daily logs. MFT will include high-intensity swallowing exercises and respiratory muscle strength training. Before and after the MFT intervention period, there will be a research visit that includes answering questionnaires about symptoms and health, performing throat HRM, and assessing oral and facial muscles involved in swallowing.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Myofunctional Therapy for Obstructive Sleep Apnea
Plain-language title
Throat muscle pressure measured in adults with obstructive sleep apnea using myofunctional therapyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07301125, who can take part
Record updated
28 October 2026